Brief: Ipsen H1 Adjusted EPS EUR 4.78
25/07/2024 06:00
Jul 25 (Reuters) - Ipsen H1 EPS EUR 2.78. * H1 EBIT EUR 317.8 million * H1 EBIT margin 19.2% * H1 adjusted EBIT EUR 538 million * H1 adjusted EBIT margin 32.4% * H1 revenue EUR 1,659.3 million
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients